Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myeloproliferative Disorders | 5 | 2024 | 609 | 1.870 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2024 | 48 | 0.910 |
Why?
|
Photoreceptor Cells, Vertebrate | 3 | 2014 | 203 | 0.880 |
Why?
|
Thymoma | 1 | 2023 | 188 | 0.750 |
Why?
|
Lymphopenia | 1 | 2023 | 281 | 0.720 |
Why?
|
Thymus Neoplasms | 1 | 2023 | 274 | 0.700 |
Why?
|
Blood Cells | 1 | 2020 | 306 | 0.610 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2024 | 614 | 0.590 |
Why?
|
Bone Marrow | 5 | 2023 | 2911 | 0.590 |
Why?
|
Parvoviridae Infections | 1 | 2017 | 36 | 0.580 |
Why?
|
Retinal Drusen | 2 | 2014 | 75 | 0.560 |
Why?
|
Hematologic Neoplasms | 3 | 2023 | 1895 | 0.550 |
Why?
|
Myelodysplastic Syndromes | 2 | 2024 | 1393 | 0.530 |
Why?
|
Skin Neoplasms | 3 | 2024 | 5809 | 0.520 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2023 | 3609 | 0.500 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2020 | 686 | 0.490 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2020 | 491 | 0.470 |
Why?
|
Testicular Neoplasms | 1 | 2020 | 800 | 0.440 |
Why?
|
Vision Disorders | 1 | 2021 | 1088 | 0.440 |
Why?
|
Geographic Atrophy | 1 | 2014 | 91 | 0.430 |
Why?
|
Liver Transplantation | 1 | 2024 | 2329 | 0.410 |
Why?
|
Dendritic Cell Sarcoma, Follicular | 2 | 2021 | 30 | 0.360 |
Why?
|
Genetic Association Studies | 1 | 2019 | 2731 | 0.330 |
Why?
|
Mutation | 9 | 2024 | 30006 | 0.300 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 3869 | 0.270 |
Why?
|
Macular Degeneration | 1 | 2013 | 1008 | 0.250 |
Why?
|
Liver | 1 | 2021 | 7513 | 0.240 |
Why?
|
Macrophages | 1 | 2020 | 5754 | 0.240 |
Why?
|
Leber Congenital Amaurosis | 2 | 2014 | 36 | 0.220 |
Why?
|
Heart Transplantation | 1 | 2017 | 3258 | 0.220 |
Why?
|
Cell Lineage | 2 | 2024 | 2547 | 0.220 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3094 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3216 | 0.200 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2024 | 212 | 0.200 |
Why?
|
Lymphoma, T-Cell | 1 | 2024 | 303 | 0.190 |
Why?
|
Hematopoiesis | 2 | 2021 | 2046 | 0.190 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2022 | 168 | 0.180 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2019 | 1605 | 0.180 |
Why?
|
Tonsillar Neoplasms | 1 | 2020 | 50 | 0.170 |
Why?
|
Blood Cell Count | 1 | 2020 | 396 | 0.160 |
Why?
|
Liver Function Tests | 1 | 2021 | 524 | 0.160 |
Why?
|
Histiocytosis, Sinus | 1 | 2019 | 44 | 0.160 |
Why?
|
Herpesvirus 4, Human | 1 | 2024 | 1076 | 0.160 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2020 | 282 | 0.150 |
Why?
|
Cell Size | 1 | 2020 | 625 | 0.150 |
Why?
|
Pathology, Molecular | 1 | 2021 | 329 | 0.150 |
Why?
|
Intranuclear Inclusion Bodies | 1 | 2017 | 34 | 0.150 |
Why?
|
Red-Cell Aplasia, Pure | 1 | 2017 | 27 | 0.150 |
Why?
|
Dendritic Cells | 3 | 2023 | 2726 | 0.150 |
Why?
|
Orchiectomy | 1 | 2020 | 463 | 0.150 |
Why?
|
Parvovirus B19, Human | 1 | 2017 | 40 | 0.140 |
Why?
|
Humans | 29 | 2024 | 761098 | 0.140 |
Why?
|
Receptors, Cell Surface | 2 | 2020 | 2802 | 0.140 |
Why?
|
Bone Marrow Examination | 1 | 2017 | 155 | 0.140 |
Why?
|
Cyclin D1 | 1 | 2019 | 451 | 0.140 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2019 | 249 | 0.140 |
Why?
|
Erythroblasts | 1 | 2017 | 142 | 0.140 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17889 | 0.140 |
Why?
|
Plasma Cells | 1 | 2020 | 597 | 0.140 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2020 | 696 | 0.140 |
Why?
|
Vacuoles | 1 | 2017 | 225 | 0.140 |
Why?
|
Nuclear Proteins | 2 | 2023 | 5781 | 0.140 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2018 | 535 | 0.140 |
Why?
|
DNA Mismatch Repair | 1 | 2020 | 428 | 0.140 |
Why?
|
Cell Transformation, Viral | 1 | 2017 | 526 | 0.130 |
Why?
|
Virus Activation | 1 | 2017 | 319 | 0.130 |
Why?
|
Lens, Crystalline | 1 | 2017 | 387 | 0.120 |
Why?
|
Janus Kinase 2 | 1 | 2018 | 559 | 0.120 |
Why?
|
cis-trans-Isomerases | 1 | 2014 | 44 | 0.120 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2019 | 592 | 0.120 |
Why?
|
Lymph Nodes | 2 | 2024 | 3461 | 0.120 |
Why?
|
Aged, 80 and over | 7 | 2020 | 58946 | 0.120 |
Why?
|
Immunotherapy, Adoptive | 1 | 2024 | 1468 | 0.120 |
Why?
|
Retinal Cone Photoreceptor Cells | 2 | 2012 | 184 | 0.120 |
Why?
|
Eosinophilia | 1 | 2019 | 557 | 0.110 |
Why?
|
Fovea Centralis | 1 | 2014 | 126 | 0.110 |
Why?
|
Immunophenotyping | 1 | 2019 | 1867 | 0.110 |
Why?
|
Aged | 10 | 2024 | 169266 | 0.110 |
Why?
|
Ophthalmoscopy | 1 | 2014 | 171 | 0.110 |
Why?
|
Retinal Photoreceptor Cell Outer Segment | 1 | 2013 | 13 | 0.110 |
Why?
|
Translocation, Genetic | 1 | 2019 | 1391 | 0.110 |
Why?
|
Forkhead Transcription Factors | 1 | 2020 | 1612 | 0.100 |
Why?
|
Neoplasms | 1 | 2021 | 22125 | 0.100 |
Why?
|
MAP Kinase Signaling System | 1 | 2019 | 1480 | 0.100 |
Why?
|
Male | 16 | 2024 | 360675 | 0.100 |
Why?
|
Immunocompromised Host | 1 | 2017 | 858 | 0.100 |
Why?
|
Guanylate Cyclase | 1 | 2012 | 205 | 0.100 |
Why?
|
Macula Lutea | 1 | 2013 | 177 | 0.100 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2024 | 4372 | 0.100 |
Why?
|
Middle Aged | 12 | 2024 | 220835 | 0.090 |
Why?
|
Cell Nucleus | 1 | 2019 | 2881 | 0.090 |
Why?
|
Tomography, Optical Coherence | 2 | 2014 | 2923 | 0.090 |
Why?
|
Sarcoma | 1 | 2021 | 1800 | 0.080 |
Why?
|
Antigens, CD | 1 | 2020 | 4008 | 0.080 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2020 | 1462 | 0.080 |
Why?
|
Biopsy | 1 | 2021 | 6781 | 0.080 |
Why?
|
Eye Proteins | 1 | 2012 | 632 | 0.080 |
Why?
|
Retinitis Pigmentosa | 1 | 2012 | 397 | 0.080 |
Why?
|
Diagnosis, Differential | 2 | 2021 | 12975 | 0.080 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2012 | 386 | 0.080 |
Why?
|
Microscopy, Confocal | 1 | 2014 | 1967 | 0.080 |
Why?
|
Retinal Degeneration | 1 | 2012 | 414 | 0.080 |
Why?
|
Alleles | 1 | 2019 | 6857 | 0.070 |
Why?
|
Neutrophils | 1 | 2020 | 3763 | 0.070 |
Why?
|
Adult | 10 | 2020 | 221083 | 0.070 |
Why?
|
Retina | 1 | 2017 | 2656 | 0.070 |
Why?
|
Immunohistochemistry | 1 | 2020 | 11066 | 0.070 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14676 | 0.060 |
Why?
|
Genotype | 1 | 2019 | 12983 | 0.060 |
Why?
|
Female | 13 | 2024 | 392458 | 0.060 |
Why?
|
Gene Rearrangement | 2 | 2019 | 1125 | 0.060 |
Why?
|
Interleukin-3 Receptor alpha Subunit | 1 | 2023 | 36 | 0.050 |
Why?
|
SOXC Transcription Factors | 1 | 2023 | 41 | 0.050 |
Why?
|
Mutation, Missense | 1 | 2012 | 2567 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5667 | 0.050 |
Why?
|
Interferon Regulatory Factors | 1 | 2023 | 261 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2019 | 11856 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 8663 | 0.040 |
Why?
|
Graft Rejection | 2 | 2024 | 4479 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2017 | 22157 | 0.040 |
Why?
|
Aging | 1 | 2017 | 8701 | 0.040 |
Why?
|
Cytogenetic Analysis | 1 | 2019 | 270 | 0.040 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2019 | 223 | 0.040 |
Why?
|
Adolescent | 4 | 2022 | 88271 | 0.040 |
Why?
|
Lipofuscin | 1 | 2017 | 40 | 0.040 |
Why?
|
Young Adult | 3 | 2020 | 59199 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2022 | 2508 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2021 | 36418 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2024 | 2549 | 0.030 |
Why?
|
Central Nervous System | 1 | 2022 | 1333 | 0.030 |
Why?
|
Biological Products | 1 | 2024 | 913 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2022 | 1624 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2023 | 4822 | 0.030 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2020 | 491 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2019 | 1837 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2023 | 2307 | 0.030 |
Why?
|
Visual Acuity | 2 | 2014 | 2677 | 0.030 |
Why?
|
Graft Survival | 1 | 2024 | 3841 | 0.030 |
Why?
|
Eye Movements | 1 | 2014 | 511 | 0.020 |
Why?
|
Retinal Rod Photoreceptor Cells | 1 | 2012 | 204 | 0.020 |
Why?
|
Catalytic Domain | 1 | 2012 | 702 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2019 | 2914 | 0.020 |
Why?
|
Multiple Myeloma | 1 | 2024 | 5145 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4109 | 0.020 |
Why?
|
Genomics | 1 | 2021 | 5828 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12727 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12467 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2024 | 80673 | 0.010 |
Why?
|
Child | 3 | 2021 | 80134 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9278 | 0.010 |
Why?
|
DNA | 1 | 2014 | 7189 | 0.010 |
Why?
|
Child, Preschool | 2 | 2012 | 42217 | 0.010 |
Why?
|
Prognosis | 1 | 2019 | 29672 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2012 | 14393 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39121 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2012 | 18217 | 0.010 |
Why?
|
Infant | 1 | 2012 | 36164 | 0.010 |
Why?
|
Cohort Studies | 1 | 2012 | 41486 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2014 | 64670 | 0.000 |
Why?
|
Mice | 1 | 2012 | 81324 | 0.000 |
Why?
|
Animals | 1 | 2012 | 168083 | 0.000 |
Why?
|